Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor pneumonitis in advanced NSCLC: a multicenter multimodal study.
- DOI
- 10.3389/fimmu.2026.1792179
- Published
- 2026
- Container
- Frontiers in immunology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fimmu.2026.1792179,
title = {Inferring tumor immune microenvironment -related risk states from pretreatment H\&E pathomics and clinical biomarkers to predict checkpoint inhibitor pneumonitis in advanced NSCLC: a multicenter multimodal study.},
author = {Yuan L and Wang Q and Sun F and Yang W and Lei J and Liu J and Fan Y and Shan Y and Lu Y and Zhang Y and Wang Y and Zhu J and Guo L and Chen W and Lu S and Shi H},
year = {2026},
journal = {Frontiers in immunology},
doi = {10.3389/fimmu.2026.1792179},
url = {https://doi.org/10.3389/fimmu.2026.1792179}
}RIS
TY - JOUR TI - Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor pneumonitis in advanced NSCLC: a multicenter multimodal study. AU - Yuan L AU - Wang Q AU - Sun F AU - Yang W AU - Lei J AU - Liu J AU - Fan Y AU - Shan Y AU - Lu Y AU - Zhang Y AU - Wang Y AU - Zhu J AU - Guo L AU - Chen W AU - Lu S AU - Shi H PY - 2026 JO - Frontiers in immunology DO - 10.3389/fimmu.2026.1792179 UR - https://doi.org/10.3389/fimmu.2026.1792179 ER -
APA
L, Y., Q, W., F, S., W, Y., J, L., J, L., Y, F., Y, S., Y, L., Y, Z., Y, W., J, Z., L, G., W, C., S, L., & H, S. (2026). Inferring tumor immune microenvironment -related risk states from pretreatment H&E pathomics and clinical biomarkers to predict checkpoint inhibitor pneumonitis in advanced NSCLC: a multicenter multimodal study.. Frontiers in immunology. https://doi.org/10.3389/fimmu.2026.1792179
Source records
- pubmed · retrieved 2026-09-26T06:49:23.830Z